Sandrine Dulong
Paris, 94270, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Interspecies and in vitro-in vivo scaling for quantitative modeling of whole-body drug pharmacokinetics in patients: Application to the anticancer drug oxaliplatin.
Journal: CPT: pharmacometrics & systems pharmacology
Published: August 11, 2022
Sex and Circadian Timing Modulate Oxaliplatin Hematological and Hematopoietic Toxicities.
Journal: Pharmaceutics
Published: August 08, 2022
Model learning to identify systemic regulators of the peripheral circadian clock.
Journal: Bioinformatics (Oxford, England)
Published: July 12, 2021
Circadian and chemotherapy-related changes in urinary modified nucleosides excretion in patients with metastatic colorectal cancer.
Journal: Scientific reports
Published: January 21, 2021
Dosing time dependent in vitro pharmacodynamics of Everolimus despite a defective circadian clock.
Journal: Cell cycle (Georgetown, Tex.)
Published: November 04, 2017
Identification of Circadian Determinants of Cancer Chronotherapy through In Vitro Chronopharmacology and Mathematical Modeling.
Journal: Molecular cancer therapeutics
Published: February 11, 2015
Functional genomics identify Birc5/survivin as a candidate gene involved in the chronotoxicity of cyclin-dependent kinase inhibitors.
Journal: Cell cycle (Georgetown, Tex.)
Published: February 21, 2014
A circadian clock transcription model for the personalization of cancer chronotherapy.
Journal: Cancer research
Published: October 25, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026